Bird Flu H5N5:
The New Strain
The first confirmed fatal human case of avian influenza A(H5N5) was published in the New England Journal of Medicine and CDC MMWR in May 2026. Here is what it means, what the CDC says about surface transmission, and which disinfectants are confirmed to kill it.
What just happened
On May 7, 2026, the New England Journal of Medicine published a letter documenting the first confirmed fatal human infection with avian influenza A(H5N5) — a strain that had never previously infected a human being. Days later, the CDC MMWR published the full case report, providing the epidemiological details of the exposure, investigation, and outcome.
The patient was a resident of Grays Harbor County, Washington — a 75-year-old woman with a history of non-Hodgkin lymphoma and recent immunosuppressive treatment who owned a backyard poultry flock. She developed fever, diarrhea, nausea, and cough in late October 2025. Initial influenza testing was negative. She was discharged with supportive care instructions. The diagnosis was confirmed weeks later after further testing — a pattern that the CDC notes complicates timely identification of novel avian influenza strains. She did not survive.
The public health investigation identified approximately 135 exposed contacts. No additional cases were detected. The CDC’s assessment remains that the overall risk to the general U.S. population from avian influenza is low. That assessment is accurate — and it does not mean the story is over.
H5N5 vs H5N1 — what is the difference and why does it matter
Both H5N1 and H5N5 are subtypes of Highly Pathogenic Avian Influenza (HPAI). The naming convention refers to two surface proteins: hemagglutinin (H) and neuraminidase (N). H5N1 has caused 880+ documented human cases across 23 countries since 2003, with a historical case fatality rate approaching 60% in confirmed cases. It has been the dominant concern in pandemic preparedness planning for two decades.
H5N5 is different in one critical respect: until October 2025, it had never infected a human. It has been circulating in wild birds and has been documented crossing into mammals — but the Washington State case represents the first confirmed human spillover event. That is precisely why virologists pay attention to new strain crossovers: each one is a data point about the virus’s evolving capacity to bridge the species gap.
H5N1 — Established Strain
- • 880+ human cases since 2003
- • ~60% case fatality rate historically
- • Widespread in poultry and dairy cows
- • Active in 23+ countries
- • Multiple human cases in US farm workers
- • Human vaccines in Phase 1b trials (Apr 2026)
- • No sustained human-to-human spread detected
H5N5 — New to Humans
- • First human case confirmed Oct 2025
- • Previously detected only in birds
- • Multiple transatlantic incursions documented
- • Spillover to mammals confirmed
- • Single fatal case — no spread detected
- • No specific vaccine or antiviral approved
- • No human-to-human transmission detected
The CDC is clear: the overall risk to the general U.S. public remains low. The populations with meaningfully elevated risk are specific: backyard poultry flock owners, farm workers with direct animal contact, veterinary staff, and immunocompromised individuals with exposure to infected birds or their environments. If you are not in regular contact with poultry, wild birds, or livestock, H5N5 does not currently represent a personal threat.
What the case does represent is a monitoring signal. Novel strain crossovers get tracked precisely because they tell scientists something about the virus’s trajectory. H5N5 infecting a human for the first time is a data point — not a cause for panic, but not something to ignore either.
Surface transmission: how avian influenza spreads in environments
The primary route of human exposure to avian influenza is direct contact with infected birds, their droppings, or contaminated environments — not person-to-person transmission. For people who work with poultry, manage backyard flocks, or handle wild birds, the contaminated surface question is directly relevant.
The good news from a disinfection standpoint: avian influenza viruses are enveloped viruses. Unlike norovirus — which has a hard protein capsid that resists many disinfectants — enveloped viruses have a lipid (fatty) outer membrane that is significantly more vulnerable to chemical disruption. The right disinfectant, applied at the right concentration and held for the required contact time, destroys enveloped viruses reliably. Avian influenza is not in the same category of surface-disinfection difficulty as norovirus or C. auris.
Avian influenza viruses can survive on surfaces for varying periods depending on temperature, humidity, and surface type. At lower temperatures, the virus can persist for days to weeks on contaminated surfaces, fecal material, water, and feed. At higher temperatures — above 56°C (133°F) for 30 minutes — the virus is inactivated by heat.
On hard, non-porous surfaces at room temperature, the CDC and USDA recommend EPA-registered disinfectants for environmental decontamination of confirmed or suspected avian influenza exposure areas. The key requirement is an EPA-registered product with an influenza A viral kill claim — not a general-purpose cleaner.
A 2026 study published in Bioorganic & Medicinal Chemistry Letters confirmed that virucidal multipurpose aqueous solutions containing quaternary ammonium compounds are effective against highly pathogenic avian influenza viruses — directly validating the active ingredient class in SONO wipes against HPAI strains.
What kills avian influenza on surfaces — confirmed data
SONO Disinfecting Wipes — FDS-confirmed avian influenza kill claims
SONO’s Formulation Data Sheet documents virucidal efficacy against multiple avian influenza strains, all at a 4-minute contact time on hard, non-porous surfaces:
Avian Influenza H3N2 — ATCC VR 2072, Strain A/Washington/897/80X and A/Mallard/New York/6750/78 — 4-minute contact time
Avian Influenza H5N1 — Strain H5N1-PR8/CDC-RG, CDC#2006719965 — 4-minute contact time
Influenza A H7N9 — 4-minute contact time
All testing conducted per EPA guidelines for presaturated towelettes for hard surface disinfection. Organic soil load: 5%. Active ingredients: Octyl decyl dimethyl ammonium chloride, Dioctyl dimethyl ammonium chloride, Didecyl dimethyl ammonium chloride, Alkyl dimethyl benzyl ammonium chloride — quaternary ammonium compounds confirmed effective against HPAI viruses in 2026 peer-reviewed research.
The enveloped virus advantage
Because avian influenza is an enveloped virus, the range of products that can kill it is broader than for non-enveloped viruses like norovirus. EPA-registered quaternary ammonium products, alcohol-based disinfectants at appropriate concentrations, and bleach solutions are all effective when used correctly. The critical variables remain the same as for any disinfection protocol: the product must be EPA-registered with the relevant viral kill claim, the surface must remain visibly wet for the required contact time, and the area must be cleaned of gross contamination before disinfection begins.
The practical protocol — avian influenza exposure cleanup
Why novel strain crossovers matter for infection control professionals
For clinical infection preventionists, veterinary staff, agricultural workers, and anyone responsible for managing environmental decontamination, the H5N5 case is a useful reminder of something that applies to every pathogen: the disinfection protocol that works for known strains also works for novel ones in the same viral family, provided the mechanism of action is correct.
Avian influenza viruses, regardless of the H and N designations, are enveloped RNA viruses. The lipid envelope that defines their structure is also the target of quaternary ammonium disinfectants. A product that kills H5N1 kills H5N5 through the same mechanism. The contact time, concentration, and surface-preparation steps do not change based on which neuraminidase subtype is involved.
“The disinfectant that works for H5N1 works for H5N5. The mechanism is the same. The contact time is the same. The preparation is the same. What changes is the strain designation — not the protocol.”
What the H5N5 case adds is a monitoring signal for infection preventionists working in settings where animal contact occurs — veterinary clinics, agricultural facilities, wildlife rehabilitation centers, and hospitals in regions with active bird flu activity. The diagnostic difficulty highlighted in the MMWR report — the patient had multiple negative influenza tests before the correct diagnosis was established — underscores the need for heightened clinical suspicion in patients with relevant exposures and novel respiratory symptoms.
SONO Disinfecting Wipes are alcohol-free, which matters in agricultural and veterinary settings where flammability, surface compatibility, and fume concerns arise. The quaternary ammonium formula that kills H5N1 at 4-minute contact time is confirmed in SONO’s Formulation Data Sheet per EPA test guidelines. Safe on equipment surfaces, examination tables, cages, and the plastic and rubber components that alcohol-based products degrade over time.
EPA Registration #6836-340-89018 • H5N1 kill claim confirmed • H3N2 kill claim confirmed • H7N9 kill claim confirmed • Alcohol-free • Bleach-free • Made in USA.
SONO Disinfecting Wipes — confirmed avian influenza kill claims
H5N1 • H3N2 • H7N9 at 4-minute contact time • EPA Reg. #6836-340-89018 • Alcohol-free • Made in USA
Shop 80ct Canister Shop 80ct Soft PackRelated Reading
→ Hantavirus: The Facts, Not the Fear — How another zoonotic virus spreads and how to disinfect properly.
→ Norovirus: The Facts, Not the Panic — Why enveloped vs non-enveloped matters for disinfection.
→ The Disinfectant Gap — Why most people are cleaning without disinfecting.
References & Sources
- Lite T-L, Goya S, Davis ML, et al. Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus. N Engl J Med. Published May 7, 2026. nejm.org
- CDC MMWR. Fatal Human Case of Highly Pathogenic Avian Influenza A(H5N5) in a Backyard Flock Owner — Washington, November 2025. MMWR Morb Mortal Wkly Rep. 2026;75(17). cdc.gov/mmwr
- CDC. Global Human Cases with Avian Influenza A(H5N1), 1997–2026. Updated May 12, 2026. cdc.gov/bird-flu
- WHO. Avian Influenza A(H5N1) — Fact Sheet. who.int
- BBC Science Focus. ‘It’s completely out of control’: Scientists warn bird flu could spark a human pandemic in 2026. sciencefocus.com
- Ogawa H, et al. Virucidal multipurpose aqueous solution containing quaternary ammonium cation and sulfobetaine is effective against highly pathogenic avian influenza viruses. Bioorg Med Chem Lett. 2026;136:130592. doi.org
- CDC Emerging Infectious Diseases. Replication Efficiency of Contemporary HPAI A(H5N1) Virus Isolates in Human Nasal Epithelium Model. Vol 32, No 5, May 2026. cdc.gov/eid
- SONO Healthcare. SONO Disinfecting Wipes Formulation Data Sheet — EPA Reg. #6836-340-89018. Avian Influenza H5N1, H3N2, H7N9 kill claims confirmed at 4-minute contact time. sonosupplies.com
